Matthew Kurtz

Matthew Kurtz is a Professor at Yale University School of Medicine, Department of Psychiatry. He received his PhD from Princeton University in 1995 and has established himself as a leading researcher in schizophrenia and cognitive remediation therapies.

Dr. Kurtz's primary research interests focus on schizophrenia spectrum disorders, with particular emphasis on cognitive remediation, social cognition, and negative symptoms. His work explores how cognitive training interventions can improve outcomes for individuals with schizophrenia, with recent investigations examining the impact of race and ethnicity on treatment efficacy, the persistence of treatment effects, and the application of metacognitive therapies.

Analysis of his recent publications reveals a strong trend toward meta-analytic approaches to evaluate treatment efficacy in schizophrenia spectrum disorders. His research bridges clinical practice with empirical evidence, focusing on evidence-based interventions that can be implemented in real-world settings. Much of his work emphasizes the importance of addressing cognitive deficits as a core component of schizophrenia treatment.

Dr. Kurtz maintains active research collaborations with several prominent colleagues at Yale, including Michal Assaf, Morris Bell, and Silvia Corbera. His research program appears to be well-established and productive, with multiple high-impact publications appearing in top psychiatry journals.